Stock listing
A2PSZH Stock Price, News, Filings & Events — Ocugen, Inc.
Selected listing: A2PSZH · LS · EUR · DE
This page tracks Ocugen, Inc.'s A2PSZH:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PSZH:LS. A2PSZH:LS is the stock-level entry point for investors researching Ocugen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2PSZH:LS
- Asset type
- Stock
- Market cap
- $471.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Ocugen, Inc. A2PSZH:LS stock context
This page tracks Ocugen, Inc.'s A2PSZH:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PSZH:LS. A2PSZH:LS is the stock-level entry point for investors researching Ocugen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ocugen, Inc.
Ocugen to Participate in Upcoming September Investor and Industry Conferences
August 25, 2026
Ocugen to Participate in Upcoming August Investor Conferences
July 31, 2026
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation ...
July 29, 2026
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
July 28, 2026
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in t...
July 13, 2026
Research Ocugen, Inc.
Ocugen, Inc. investor report
Review AI stock analysis and investor report context for A2PSZH:LS.
Ocugen, Inc. company profile
View the public company page for Ocugen, Inc. on 6ix.
Ocugen, Inc. news
Read company news and market updates connected to Ocugen, Inc..
Ocugen, Inc. investor events
Find investor webinars, events, and replay context for Ocugen, Inc..
Alternate listings
OCGN:NASDAQ
US · USD
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
2H51:GETTEX
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
2H51:TRADEGATE
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
A2PSZH:LSX
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
OCGN:BMV
MX · MXN
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
2H51:FWB
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
2H51:SWB
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
2H51:MUN
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
2H51:DUS
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
OCGN:BOATS
US · USD
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
OCGN:BIVA
MX · MXN
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.
2H51:HAM
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is A2PSZH:LS.